BDBM50099713 CHEMBL50878::N-(9,10-Dioxo-9,10-dihydro-phenanthren-2-yl)-2-fluoro-benzamide

SMILES Fc1ccccc1C(=O)Nc1ccc-2c(c1)C(=O)C(=O)c1ccccc-21

InChI Key InChIKey=BYGWCJMXSGBHQK-UHFFFAOYSA-N

Data  9 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 9 hits for monomerid = 50099713   

TargetProcathepsin L(Human)
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50099713(N-(9,10-Dioxo-9,10-dihydro-phenanthren-2-yl)-2-flu...)
Affinity DataIC50: 400nMAssay Description:Inhibitory concentration against Cathepsin LMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetReceptor-type tyrosine-protein phosphatase C(Human)
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50099713(N-(9,10-Dioxo-9,10-dihydro-phenanthren-2-yl)-2-flu...)
Affinity DataIC50: 600nMAssay Description:In vitro inhibitory activity against the cytosolic portion of CD45 protein-tyrosine phosphatase using pNPP as the substrateMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetReceptor-type tyrosine-protein phosphatase C(Human)
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50099713(N-(9,10-Dioxo-9,10-dihydro-phenanthren-2-yl)-2-flu...)
Affinity DataIC50: 600nMAssay Description:Inhibitory concentration against CD45 protein-tyrosine phosphatase pNPPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetTyrosine-protein phosphatase non-receptor type 13(Human)
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50099713(N-(9,10-Dioxo-9,10-dihydro-phenanthren-2-yl)-2-flu...)
Affinity DataIC50: 600nMAssay Description:Inhibitory concentration against FAP-1 pNPPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin S(Human)
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50099713(N-(9,10-Dioxo-9,10-dihydro-phenanthren-2-yl)-2-flu...)
Affinity DataIC50: 9.00E+3nMAssay Description:Inhibitory concentration against Cathepsin SMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin B(Human)
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50099713(N-(9,10-Dioxo-9,10-dihydro-phenanthren-2-yl)-2-flu...)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibitory concentration against Cathepsin BMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetReceptor-type tyrosine-protein phosphatase C(Human)
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50099713(N-(9,10-Dioxo-9,10-dihydro-phenanthren-2-yl)-2-flu...)
Affinity DataIC50: 1.10E+4nMAssay Description:Inhibitory concentration against CD45 protein-tyrosine phosphatase using lck-10 mer as substrateMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetTyrosine-protein phosphatase non-receptor type 1(Human)
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50099713(N-(9,10-Dioxo-9,10-dihydro-phenanthren-2-yl)-2-flu...)
Affinity DataIC50: 1.80E+4nMAssay Description:Inhibitory concentration against PTP1B using lck as substrateMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetTyrosine-protein phosphatase non-receptor type 13(Human)
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50099713(N-(9,10-Dioxo-9,10-dihydro-phenanthren-2-yl)-2-flu...)
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibitory concentration against FAP-1 using lck-10 mer as substrateMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed